Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Jie Fu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5864-3488; OpenAlex author ID A5100666923. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Effect of Donor and Acceptor on Improving the ROS Generation of Benzothiadiazole-Based Photosensitizers and Effective Photodynamic Therapy to Pancreatic Cancer… Co-author DOI 10.1002/bio.70314↗
  2. Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma via bioinformatic an… Last author DOI 10.7717/peerj.12141↗
  3. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. Co-author DOI 10.1038/onc.2017.393↗
  4. Inhibition of Pancreatic Cancer by RhIL1RA-Response. Co-author DOI 10.1158/1078-0432.ccr-17-0083↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Muzhou Teng · 1 shared paper, 2025 · strength 0.27
  2. Jianhua Ling · 2 shared papers, 2017–2018 · strength 0.17
  3. Paul J. Chiao · 2 shared papers, 2017–2018 · strength 0.17
  4. Xiaohua Lei · 1 shared paper, 2021 · strength 0.16
  5. Guodong Chen · 1 shared paper, 2021 · strength 0.16
  6. Yi-Chen Sun · 1 shared paper, 2017 · strength 0.09
  7. Lu Yu · 1 shared paper, 2017 · strength 0.09
  8. Xianjun Yu · 1 shared paper, 2018 · strength 0.08
  9. H Zhou · 1 shared paper, 2018 · strength 0.08
  10. Shunrong Ji · 1 shared paper, 2018 · strength 0.08
  11. Yi Qin · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.